🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

AstraZeneca facing two London lawsuits over COVID-19 vaccines

Published 23/08/2023, 16:17
© Reuters. FILE PHOTO: A vial and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration taken, November 27, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
AZN
-
AZN
-

By Sam Tobin

LONDON (Reuters) - AstraZeneca (NASDAQ:AZN) is facing two London lawsuits, including one from the husband of a woman who died after receiving the Anglo-Swedish drugmaker's COVID-19 vaccine, in the first of potentially dozens of cases brought in England.

Britain was the first country to roll out the at-cost AstraZeneca COVID-19 vaccine in early 2021, although it later restricted the use of it among under 40s due to the small risk of blood clots.

Anish Tailor, whose wife Alpa died in March 2021 after receiving her first dose of the vaccine, filed a product liability claim against AstraZeneca at London's High Court on Aug. 4, according to court records.

His lawyer Peter Todd, from the law firm Scott-Moncrieff & Associates, told Reuters that he has nearly 50 other clients who will formally sue AstraZeneca in the coming months.

AstraZeneca declined to comment on active legal cases. A spokesperson said in a statement: "Patient safety is our highest priority and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines.

"Our sympathy goes out to anyone who has lost loved ones or reported health problems."

AstraZeneca is facing a similar lawsuit from Jamie Scott, who was diagnosed with vaccine-induced thrombotic thrombocytopenia, which can cause fatal blood clotting, after receiving the AstraZeneca vaccine.

Scott filed a product liability lawsuit against AstraZeneca on Monday, according to court records. No filings or further details about the case were immediately available.

Hausfeld, the law firm representing Scott, said it represents around 40 other individuals or bereaved families.

Sarah Moore, a lawyer at Hausfeld, said in a statement that Scott had "suffered life-changing injuries which have severely impacted not only him, but those close to him".

© Reuters. FILE PHOTO: AstraZeneca's site in Macclesfield, Britain, May 11, 2021. REUTERS/Phil Noble/File Photo

She said Scott will argue AstraZeneca is "liable to compensate him for what he has suffered so that he can rebuild his life as far as possible and ensure the security of his family".

The two cases are the first lawsuits brought in England and Wales over an adverse reaction to a COVID-19 vaccine, according to publicly-available court records.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.